Hemoglobin and plasma Vitamin C levels in patients on peritoneal dialysis

Peritoneal Dialysis International

Volumn 31, Issue 1, 2011, Pages 74-79

  Finkelstein, Fredric O ^a,b,c   Juergensen, Peter ^a   Wang, Suxin ^d   Santacroce, Sally ^a   Levine, Mark ^e   Kotanko, Peter ^f   Levin, Nathan W ^f   Handelman, Garry J ^d,f  

^a New Haven CAPD   (United States)

^b HOSPITAL OF SAINT RAPHAEL   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f RENAL RESEARCH INSTITUTE   (United States)

Author keywords

Anemia; Hemoglobin; Vitamin C

Indexed keywords

ASCORBIC ACID; C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; TRANSFERRIN;

ADULT; BLOOD OXYGEN TENSION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FUNCTION TEST; LONG TERM CARE; MALE; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; SENSITIVITY ANALYSIS; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; MIDDLE AGED;

ASCORBIC ACID; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS;

EID: 79953774756     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2009.00154     Document Type: Review

References (38)

1. Bridges KR, Hoffman KE. The effects of ascorbic acid on the intracellular metabolism of iron and ferritin. J Biol Chem 1986; 261:14273-7.
2. Smith CH, Bidlack WR. Interrelationship of dietary ascorbic acid and iron on the tissue distribution of ascorbic acid, iron and copper in female guinea pigs. J Nutr 1980; 110: 1398-408.
3. Boyer RF, Grabill TW, Petrovich RM. Reductive release of ferritin iron: a kinetic assay. Anal Biochem 1988; 174: 17-22.
4. Cooper LHN. Some conditions governing the solubility of iron. Proc R Soc Lond B Biol Sci 1937; 124:299-307.
5. Hallberg L, Brune M, Rossander L. The role of vitamin C in iron absorption. Int J Vitam Nutr Res Suppl 1989; 30:103-8.
6. Zhu L, Glahn RP, Yeung CK, Miller DD. Iron uptake by Caco-2 cells from NaFeEDTA and FeSO4: effects of ascorbic acid, pH, and a Fe(ii) chelating agent. J Agric Food Chem 2006; 54:7924-8.
7. Thankachan P, Walczyk T, Muthayya S, Kurpad AV, Hurrell RF. Iron absorption in young Indian women: the interaction of iron status with the influence of tea and ascorbic acid. Am J Clin Nutr 2008; 87:881-6.
8. Fidler MC, Davidsson L, Zeder C, Walczyk T, Hurrell RF. Iron absorption from ferrous fumarate in adult women is influenced by ascorbic acid but not by Na2EDTA. Br J Nutr 2003; 90:1081-5.
9. Richter A, Kuhlmann MK, Seibert E, Kotanko P, Levin NW, Handelman GJ. Vitamin C deficiency and secondary hyperparathyroidism in chronic haemodialysis patients. Nephrol Dial Transplant 2008; 23:2058-63. Epub 19 Mar 2008 as doi:10.1093/ndt/gfn084.
10. Descombes E, Boulat O, Perriard F, Fellay G. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation. Artif Organs 2000; 24:773-8.
11. Descombes E, Hanck AB, Fellay G. Water soluble vitamins in chronic hemodialysis patients and need for supplementation. Kidney Int 1993; 43:1319-28.
12. Lee EJ, Myint CC, Tay ME, Yusuf N, Ong CN. Serum ascorbic acid and protein calorie malnutrition in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17:219-22.
13. Lim SL, Lee EJ, Myint CC, Ong KT, Tay ME, Yusuf N, et al. Oral intake and serum levels of ascorbic acid in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17:215-18.
14. Singer R, Rhodes HC, Chin G, Kulkarni H, Ferrari P. High prevalence of ascorbate deficiency in an Australian peritoneal dialysis population. Nephrology (Carlton) 2008; 13: 17-22.
15. Bohm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation. Int J Vitam Nutr Res 1997; 67:262-6.
16. Mydlik M, Derzsiova K, Svac J, Dlhopolcek P, Zemberova E. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 1998; 22:784-8.
17. Sundl I, Roob JM, Meinitzer A, Tiran B, Khoschsorur G, Haditsch B, et al. Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress. Perit Dial Int 2009; 29:89-101.
18. Zwolinska D, Grzeszczak W, Szczepanska M, Makulska I, Kilis-Pstrusinska K, Szprynger K. Oxidative stress in children on peritoneal dialysis. Perit Dial Int 2009; 29:171-7.
19. Mydlik M, Derzsiova K, Valek A, Szabo T, Dandar V, Takac M. Vitamins and continuous ambulatory peritoneal dialysis (CAPD). Int Urol Nephrol 1985; 17:281-6.
20. Handelman GJ. Vitamin C deficiency in dialysis patients-are we perceiving the tip of an iceberg? Nephrol Dial Transplant 2007; 22:328-31.
21. Margolis SA, Duewer DL. Measurement of ascorbic acid in human plasma and serum: stability, intralaboratory repeatability, and interlaboratory reproducibility. Clin Chem 1996; 42:1257-62.
22. Levine M, Wang Y, Rumsey SC. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol 1999; 299:65-76.
23. Deicher R, Ziai F, Bieglmayer C, Schillinger M, Horl WH. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients. J Am Soc Nephrol 2005; 16:1811-18.
24. Deicher R, Ziai F, Habicht A, Bieglmayer C, Schillinger M, Horl WH. Vitamin C plasma level and response to erythropoietin in patients on maintenance haemodialysis. Nephrol Dial Transplant 2004; 19:2319-24.
25. Tarng DC, Wei YH, Huang TP, Kuo BI, Yang WC. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int 1999; 55:2477-86.
26. Keven K, Kutlay S, Nergizoglu G, Erturk S. Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients. Am J Kidney Dis 2003; 41: 1233-9.
27. Lin CL, Hsu PY, Yang HY, Huang CC. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload. Ren Fail 2003; 25:445-53.
28. Wang S, Geraci G, Kuhlmann MK, Levin NW, Handelman GJ. Chemical reactions of vitamin C with intravenous-iron formulations. Nephrol Dial Transplant 2008; 23:120-5.
29. National Institutes of Standards and Technology. SRM #970: Ascorbic acid in human plasma. Gaithersburg, MD; 2001.
30. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-43.
31. Brugnara C. Use of reticulocyte cellular indices in the diagnosis and treatment of hematological disorders. Int J Clin Lab Res 1998; 28:1-11.
32. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003; 49:1573-8.
33. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006; 1(Suppl 1):S4-8.
34. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ, et al. Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 1996; 63:760-5.
35. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109:144-8.
36. Evans-Olders R, Eintracht S, Hoffer J. Metabolic origin of hypovitaminosis C in acutely hospitalized patients. Nutrition 2010; [in press]; epub 16 Dec 2009 as doi:10.1016/j.nut.2009.08.015.
37. Kang JY. The gastrointestinal tract in uremia. Dig Dis Sci 1993; 38:257-68.
38. Kotanko P, Carter M, Levin NW. Intestinal bacterial microflora-a potential source of chronic inflammation in patients with chronic kidney disease. Nephrol Dial Transplant 2006; 21:2057-60.